Your session is about to expire
← Back to Search
Baloxavir and Oseltamivir for Influenza
Study Summary
This trial will compare the effectiveness of two different drugs in preventing influenza outbreaks in nursing homes.
- Flu
- Influenza
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are a long-stay resident of a NH in the United States.
- Group 1: Oseltamivir
- Group 2: Baloxavir
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Baloxavir received regulatory approval from the Food and Drug Administration?
"The safety of Baloxavir has been established through its Phase 4 trial, thus earning a score of 3."
What are the traditional applications of Baloxavir?
"Baloxavir is typically prescribed for fever, but it also has the potential to be used in combating influenza pandemics. Furthermore, this medication can help mitigate symptoms related to Influenza A and B viruses."
Is a person of any age below 55 years old able to partake in this research?
"Per the guidelines of this medical trial, anyone between 18 years and 120 years old is welcome to participate."
Is there still a possibility to join this research endeavor?
"Clinicaltrials.gov indicates that this medical research is presently seeking participants, with the trial being initially published on August 6th 2021 and having been most recently updated on November 18th 2022."
What previous research has been undertaken regarding the efficacy of Baloxavir?
"Presently, there are 11 clinical trials researching Baloxavir. 2 of these active investigations have progressed to Phase 3. The majority of research on this drug is conducted in New york City, although 351 sites worldwide host studies for it."
How many individuals have signed up to take part in this investigation?
"Affirmative. The information hosted on clinicaltrials.gov implies that this research endeavour, which was initially posted on August 6th 2021, is actively searching for participants. Approximately 1000 individuals need to be sourced from a single medical centre."
Is my eligibility in compliance with the requirements for this experiment?
"1000 participants are being sought for this influenza trial, which is open to humans aged 18 or above and 120 or below."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger